Our previous study found that Calhm2 expression was increased in AD model mice, and that knockout of Calhm2 improved Aβ plaque deposition, reduced neuroinflammation, and improved cognitive impairment in AD model mice. This evidence concerns the gene CALHM2 and Alzheimer disease.